SKIN TECH

Brand Owner (click to sort) Address Description
SKIN-TEX CHAUCER (U.S.A.), INC. BOX 49 LAUREL AVENUE GROVER NC 28073 SKIN TECH;TEXTILE FABRICS MADE OF COMBINATIONS OF NATURAL AND SYNTHETIC FIBERS FOR USE IN THE MANUFACTURE OF CLOTHING AND SLEEPWEAR FOR MEN, WOMEN AND CHILDREN, AND FOR USE IN THE MANUFACTURE OF BEDDING PRODUCTS, NAMELY, SHEETS, PILLOWCASES, BED BLANKETS, BEDSPREADS, BED RUFFLES, PILLOW SHAMS, COMFORTERS AND DUST RUFFLES, AND FOR USE IN THE MANUFACTURE OF SOFT WINDOW TREATMENTS, NAMELY, DRAPERIES, CURTAINS AND VALANCES;
SKINTECH Skintech Pty. Ltd. 17 Market Street Suite 6A Level 1 Box Hill, Victoria 3128 Australia SKIN TECH;cosmetics; skin care products, namely, facial moisturizers, facial toners, facial cleansers, facial clarifiers, eye creams, and facial soap; and sun screen preparations;
SKINTECH Huntingdon Mills (Canada) Ltd. 72 Dalhousie Huntingdon J0S 1H0 Canada SKIN TECH;Textile fabric used as the principal component or as the insulating liner in the manufacture of clothing, namely underwear, hats, gloves, footwear, namely boots, shoes and slippers, blankets, scarves, and inner and outer sportswear, sleepwear and casualwear;
SKINTECH Effectsrx 2037 LEE MOUNTAIN RD DOVER AR 72837 SKIN TECH;Cosmetics, Non-medicated skin care preparations, anti-oxidant skin cream, skin toner, facial wash, exfoliating skin cream, facial cleanser, anti-aging skin preparations, namely, anti-aging creams, wrinkle reducing preparation in the nature of anti-wrinkle creams and plumping preparations in the nature of non-medicated skin plumping preparations, non-medicated stem cell skin care preparations, skin moisturizer, non-medicated therapeutic skin care preparation, non-medicated retinol and peptide skin preparations, eye cream;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. Whether or not a sample of skin or of a skin equivalent contains such amount of a papillary fibroblast population as to be considered a normal skin is determined by labelling said skin or skin equivalent with at least one antibody specific for papillary fibroblasts and evaluating the extent of such labelling as a marker for skin or skin equivalent quality.